Henry Schein, Inc. (NASDAQ:HSIC) EVP Mark E. Mlotek sold 5,559 shares of the business’s stock in a transaction dated Friday, March 17th. The stock was sold at an average price of $170.98, for a total transaction of $950,477.82. Following the sale, the executive vice president now directly owns 40,426 shares in the company, valued at approximately $6,912,037.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Henry Schein, Inc. (NASDAQ:HSIC) traded up 0.09% during trading on Monday, hitting $171.41. 366,792 shares of the company’s stock were exchanged. The firm has a market cap of $13.57 billion, a price-to-earnings ratio of 27.69 and a beta of 1.02. The company’s 50-day moving average price is $168.06 and its 200 day moving average price is $159.48. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $183.00.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 21st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.03. The company earned $3.12 billion during the quarter, compared to analysts’ expectations of $3.08 billion. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. Henry Schein’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period last year, the business earned $1.67 EPS. Equities analysts forecast that Henry Schein, Inc. will post $7.25 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Henry Schein (NASDAQ:HSIC)

Your IP Address:

HSIC has been the topic of several research reports. Gabelli raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $208.00 price objective on the stock in a research note on Tuesday, January 10th. Evercore ISI lifted their target price on shares of Henry Schein from $160.00 to $178.00 and gave the stock a “hold” rating in a report on Tuesday, February 21st. Deutsche Bank AG started coverage on shares of Henry Schein in a report on Wednesday, March 15th. They issued a “hold” rating and a $174.00 target price for the company. Jefferies Group LLC reaffirmed a “hold” rating and issued a $165.00 target price on shares of Henry Schein in a report on Tuesday, February 28th. Finally, Leerink Swann set a $183.00 target price on shares of Henry Schein and gave the stock a “hold” rating in a report on Wednesday, February 22nd. Nine research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $180.84.

Hedge funds have recently added to or reduced their stakes in the company. MSI Financial Services Inc boosted its stake in Henry Schein by 3.9% in the third quarter. MSI Financial Services Inc now owns 3,437 shares of the company’s stock worth $560,000 after buying an additional 130 shares during the period. Genesee Valley Trust Co. bought a new stake in Henry Schein during the third quarter worth approximately $261,000. Atria Investments LLC bought a new stake in Henry Schein during the third quarter worth approximately $229,000. Legacy Private Trust Co. boosted its stake in Henry Schein by 4.2% in the third quarter. Legacy Private Trust Co. now owns 6,640 shares of the company’s stock worth $1,082,000 after buying an additional 270 shares during the period. Finally, Creative Planning boosted its stake in Henry Schein by 8.3% in the third quarter. Creative Planning now owns 7,065 shares of the company’s stock worth $1,151,000 after buying an additional 539 shares during the period. Institutional investors own 90.91% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.